|
CLVRW
|
Clever Leaves Holdings Inc
|
US
|
US
|
|
CLVS
|
Clovis Oncology, Inc.
|
US
|
NASDAQ
|
|
CLXT
|
Calyxt, Inc.
|
US
|
NASDAQ
|
|
CMRAW
|
Comera Life Sciences Holdings Inc
|
US
|
US
|
|
CMRX
|
Chimerix, Inc.
|
US
|
NASDAQ
|
|
CNCE
|
Concert Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CNTG
|
Centogene N.V.
|
US
|
NASDAQ
|
|
CNW
|
CO.DON AG INH. O.N.
|
DE
|
F
|
|
COEPW
|
Coeptis Therapeutics Holdings Inc
|
US
|
US
|
|
COGT
|
Cogent Biosciences, Inc.
|
US
|
NASDAQ
|
|
CONCORDBIO
|
Concord Biotech Limited
|
IN
|
BSE
|
|
CONCORDBIO
|
Concord Biotech Limited
|
IN
|
NSE
|
|
COTQF
|
Critical Outcome Technologies Inc
|
US
|
OTC
|
|
CPRX
|
Catalyst Pharmaceutical Partners, Inc.
|
US
|
NASDAQ
|
|
CRBP
|
Corbus Pharmaceuticals Holdings, Inc.
|
US
|
NASDAQ
|
|
CRDF
|
Cardiff Oncology, Inc.
|
US
|
NASDAQ
|
|
CRIS
|
Curis, Inc.
|
US
|
NASDAQ
|
|
CRNA
|
Circio Holding ASA
|
NO
|
OL
|
|
CRNO-B
|
Cereno Scientific AB Series B
|
SE
|
ST
|
|
CRNX
|
Crinetics Pharmaceuticals, Inc.
|
US
|
NASDAQ
|